Michael H. Davidson to Capecitabine
This is a "connection" page, showing publications Michael H. Davidson has written about Capecitabine.
Connection Strength
0.133
-
A phase 1b trial of the combination of an all-oral regimen of capecitabine and erlotinib in advanced non-small cell lung cancer in Caucasian patients. Cancer Chemother Pharmacol. 2016 Feb; 77(2):375-83.
Score: 0.133